drugset / Trial / NCT00473720
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
NaSingle-groupOpen-labelTreatment
Summary
This is a phase I dose escalating study of oral satraplatin in combination with Abraxane administered weekly for three out of every four weeks in patients with advanced solid cancers.
Timeline
- Start
- 2007-05
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 80 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 100 mg/m2 | — |
| Subject | Satraplatin | Other / unclassified | 40 mg/m2 | Oral |
| Subject | Satraplatin | Other / unclassified | 60 mg/m2 | Oral |
| Subject | Satraplatin | Other / unclassified | 80 mg/m2 | Oral |